IBD 50 Stocks To Watch: Is This Drug Company's Stock A Buy?
- Oops!Something went wrong.Please try again later.
- AZN
One of several medical stocks on the IBD 50 list of growth stocks, drug giant AstraZeneca is trying to break out of a new base as the stock market struggles to remain in a confirmed uptrend. The U.K.- based maker of a wide variety of treatments is forming a double-bottom base, according to MarketSmith chart analysis. Its drugs include a Covid vaccine and cancer drugs Tagrisso, Imfinzi and Lynparza.